# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-20-000122
Filing Date
2020-11-06
Accepted
2020-11-06 16:11:48
Documents
65
Period of Report
2020-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lgnd-20200930.htm iXBRL | 10-Q | 1697266
2 | EX-2.5 | exhibit25ligand-cvragr.htm | EX-2.5 | 110277
3 | EX-10.2 | exhibit102ligandcydexg.htm | EX-10.2 | 31196
4 | EX-31.1 | lgnd_93020exhibit311.htm | EX-31.1 | 16579
5 | EX-31.2 | lgnd_93020exhibit312.htm | EX-31.2 | 16918
6 | EX-32.1 | lgnd_93020exhibit321.htm | EX-32.1 | 11411
12 |  | lgnd-20200930_g1.jpg | GRAPHIC | 11735
| Complete submission text file | 0000886163-20-000122.txt |  | 8449432

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lgnd-20200930.xsd | EX-101.SCH | 49928
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lgnd-20200930_cal.xml | EX-101.CAL | 119087
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lgnd-20200930_def.xml | EX-101.DEF | 335739
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lgnd-20200930_lab.xml | EX-101.LAB | 704521
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lgnd-20200930_pre.xml | EX-101.PRE | 430291
13 | EXTRACTED XBRL INSTANCE DOCUMENT | lgnd-20200930_htm.xml | XML | 1540184

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 201294533
SIC: 2834 Pharmaceutical Preparations